<DOC>
	<DOC>NCT00408330</DOC>
	<brief_summary>This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.</brief_summary>
	<brief_title>A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face</brief_title>
	<detailed_description>To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Seborrheic</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Stable or exacerbating seborrheic dermatitis in the facial area Psoriasis Atopic dermatitis Facial acne and rosacea Dermatophytic skin infections Parkinson's disease Known immunosuppression; HIV infection Any condition requiring continuous systemic or topical corticosteroid or antimycotic therapy Continuous asthma inhalation treatment requiring &gt; 800 mg corticosteroids Any severe disease likely to interfere with the conduct or the planned termination of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>